Mitochondrial dysfunction represents one of the earliest detectable changes in Alzheimer's disease, often preceding the characteristic amyloid plaques and tau tangles by years. This cellular energy crisis may explain why current treatments targeting late-stage pathology show limited success. A new mechanistic study reveals how a thousand-year-old Chinese herbal formula called Kai-Xin-San directly addresses this fundamental metabolic breakdown through an unexpected pathway involving folate metabolism.
Researchers used APP/PS1 transgenic mice to demonstrate that Kai-Xin-San granules significantly improved learning and memory while preserving hippocampal neurons and reducing amyloid-beta accumulation. Proteomic analysis revealed the formula's active compounds concentrate in brain tissue and specifically target dihydrofolate reductase (DHFR), a critical enzyme in folate metabolism that directly influences mitochondrial energy production. The team validated this mechanism using both transgenic mice and cultured neurons overexpressing amyloid precursor protein, showing consistent mitochondrial protection across experimental models.
This finding bridges traditional medicine with modern neuroscience by identifying a novel therapeutic target that addresses Alzheimer's at the cellular energy level rather than just protein aggregation. Folate metabolism dysfunction has emerged as an underappreciated factor in neurodegeneration, with mounting evidence linking folate deficiency to cognitive decline in aging populations. The DHFR pathway represents a potentially modifiable target that could influence disease progression much earlier than current interventions. However, the complexity of herbal formulations makes isolating active compounds challenging, and human clinical validation remains essential before therapeutic applications can be considered.